Latest Comments

Promising preliminary data from Phase II study encourages Axovant to expand trial

Promising preliminary data from Phase II study encourages Axovant to expand trial

Merck’s Verubecestat marks a new era for Alzheimer’s treatment

Merck’s Verubecestat marks a new era for Alzheimer’s treatment